Composition for inhibiting tyrosinase activity and application thereof
A whitening flash-release tablet was prepared by combining a combination of cantaloupe powder, prickly pear powder, passion fruit powder, and apple powder with mannitol, xanthan gum, and pullulan. This method solves the problems of unsatisfactory effects and complex processes in existing whitening products, and achieves rapid disintegration, significant whitening effect, and high bioavailability.
Patent Information
- Application Number
- CN202310328974.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-03-30
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2043-03-30
AI Technical Summary
Existing whitening and freckle-removing products have unsatisfactory melanin-inhibiting effects. Traditional whitening pills have problems such as slow dissolution, low bioavailability, and difficulty in swallowing. Furthermore, existing flash-release tablets have complex processes and high costs, making them unsuitable for widespread application in the food industry.
A combination of cantaloupe powder, prickly pear powder, passion fruit powder, and apple powder was used as a composition to inhibit tyrosinase activity. Mannitol, xanthan gum, and pullulan were used as matrix agents and binders to prepare a whitening flash-release formulation. Tablets were prepared by mixing, dissolving, and lyophilizing.
It achieves rapid disintegration, significantly inhibits tyrosinase activity, improves bioavailability, has a significant whitening effect, is simple to process, is suitable for industrial production, and the raw materials are safe and edible.
Smart Images

Figure CN116135046B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of food and health products, and relates to a composition for inhibiting tyrosinase activity and an application thereof, and specifically relates to a composition for inhibiting tyrosinase activity and a whitening flash-release preparation prepared therefrom. Background Art
[0002] "Skin whiter than snow" has always been the mainstream of oriental aesthetic culture. Under the influence of the concept of "whiteness can cover up all ugliness", "whole body white" has become the persistent pursuit of most women. Therefore, oral whitening and freckle removal products have become the favorite of women who pursue "skin whiter than snow". If you want white skin, the key is to inhibit the production of melanin. Melanin is affected by internal factors such as various enzymes and cytokines, mainly tyrosinase, and external factors such as medium and long-wave ultraviolet rays [He Yifan, Long Yunluan, Li Zheng, et al. Research progress on the mechanism of action of natural plant whitening ingredients. Daily Chemicals Science, 2022(010):045]. The whitening and freckle removal products currently on the market mainly work by inhibiting the proliferation and differentiation of melanocytes, inhibiting melanin synthase, blocking the transport of melanin particles, accelerating the metabolism of epidermal cells, and blocking the signal transduction pathways in the process of melanin production [Yang Xin, Lu Yuhe, Mao Yinxue, Niu Shurui, Dong Zibo, Qin Kunming. Research on the active ingredients and action mechanisms of whitening traditional Chinese medicine. Food and Drug, 2021, 23(06): 578-584].
[0003] Flash-release tablets can be absorbed mainly through the sublingual mucosa and buccal mucosa, enter the blood, and then enter the human body fluid circulation system. Because this method is absorbed in the oral cavity, it can avoid the destruction of the effective ingredients by organs such as the stomach and intestines; avoid the first-pass effect of the liver and various barrier effects in the human body; more importantly, the oral cavity is very close to the facial skin, so the effective ingredients absorbed by the oral mucosa can be transported or diffused in the facial skin at a greater concentration, thereby exerting a greater effect. CN112971150B discloses a γ-aminobutyric acid-containing saccharide freeze-dried flash-release tablet. The patent uses a freeze-drying curve for freeze-drying. The freeze-drying time takes about 14 hours, which is relatively long; CN108033970A discloses a Physalis active extract and extraction method and application. The operation process is complicated, involving a variety of organic reagents, and the obtained active ingredients cannot be used in food. CN112870173A discloses a freeze-dried flash-release tablet and a preparation method thereof. The adhesive selected for the freeze-dried flash-release tablet is a polyethylene caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, which is not a usable food additive.
[0004] However, on the one hand, the melanin inhibition effect of these whitening products disclosed is not ideal, so their whitening effect is relatively limited. On the other hand, for flash-release tablets, since disintegrants such as sodium carboxymethyl starch, cross-linked sodium carboxymethyl cellulose, and cross-linked polyvinylpyrrolidone are not within the scope of applicable additives for food tablets and candies, orally disintegrating tablets are limited in application in the food field. Traditional whitening pills have many shortcomings, such as (1) slow oral dissolution rate and low bioavailability; (2) whitening pills on the market are large in size and difficult to swallow, and need to be taken with warm water.
[0005] Therefore, based on the shortcomings of existing technology, there is an urgent need to develop a whitening flash-release tablet with clear and significant efficacy, fast oral dissolution, simple process and excellent taste. Summary of the invention
[0006] In view of the deficiencies of the prior art, the object of the present invention is to provide a composition for inhibiting tyrosinase activity and its application, specifically to provide a composition for inhibiting tyrosinase activity and a whitening flash-release preparation prepared therefrom.
[0007] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:
[0008] In a first aspect, the present invention provides a composition for inhibiting tyrosinase activity, the composition comprising cantaloupe powder, roxburgh powder, passion fruit powder and apple powder.
[0009] Muskmelon is rich in superoxide dismutase (SOD), which can effectively act on the melanin formation process, reduce melanin precipitation in the skin, and make the skin translucent and white. Rosa roxburghii is known as the "king of vitamin C", and vitamin C plays an important role in inhibiting melanocytes, promoting skin collagen regeneration, anti-aging, and prolonging female adolescence. Passionflower is rich in piceatannol, which has the effect of whitening and anti-aging, can activate the regeneration of skin fibroblasts, promote collagen synthesis, inhibit melanin production, and improve skin sagging and dullness; apples are rich in polyphenolic compounds such as proanthocyanidins, which have strong antioxidant activity and other physiological functions. Apple polyphenols can inhibit tyrosinase activity in melanoma cells and promote anti-melanin production. Apple polyphenols help improve the facial skin condition of healthy women and pigmentation induced by ultraviolet radiation.
[0010] The invention creatively combines roxburghii powder, apple powder, cantaloupe powder and passion fruit powder. The four components cooperate with each other and have a synergistic effect in inhibiting tyrosinase activity, inhibiting melanin production and whitening effect.
[0011] Preferably, the composition comprises, by weight, 5 to 50 parts of cantaloupe powder, 50 to 300 parts of roxburghii powder, 15 to 60 parts of passion fruit powder and 40 to 200 parts of apple powder.
[0012] Specific numerical values in the above 5 to 50 parts are, for example, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, etc.
[0013] Specific numerical values among the above 50 to 300 parts include 50 parts, 60 parts, 70 parts, 80 parts, 90 parts, 100 parts, 110 parts, 120 parts, 130 parts, 140 parts, 150 parts, 160 parts, 170 parts, 180 parts, 190 parts, 200 parts, 210 parts, 220 parts, 230 parts, 240 parts, 250 parts, 260 parts, 270 parts, 280 parts, 290 parts, 300 parts, etc.
[0014] Specific numerical values in the above 15 to 60 parts are, for example, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, etc.
[0015] Specific numerical values in the above 40 to 200 parts include, for example, 40 parts, 50 parts, 60 parts, 70 parts, 80 parts, 90 parts, 100 parts, 110 parts, 120 parts, 130 parts, 140 parts, 150 parts, 160 parts, 170 parts, 180 parts, 190 parts, 200 parts, etc.
[0016] Further preferably, the composition comprises, by weight, 5 to 50 parts of cantaloupe powder, 200 to 300 parts of roxburghii powder, 15 to 60 parts of passion fruit powder and 40 to 200 parts of apple powder.
[0017] More preferably, the composition comprises, by weight, 5 to 15 parts of cantaloupe powder, 220 to 280 parts of roxburghii powder, 30 to 50 parts of passion fruit powder and 40 to 60 parts of apple powder.
[0018] In a second aspect, the present invention provides use of the composition for inhibiting tyrosinase activity as described in the first aspect in the preparation of a tyrosinase activity inhibitor.
[0019] In a third aspect, the present invention provides use of the composition for inhibiting tyrosinase activity as described in the first aspect in preparing a product with whitening effect.
[0020] In a fourth aspect, the present invention provides a whitening flash-release preparation, the composition of which includes the composition for inhibiting tyrosinase activity as described in the first aspect, a skeleton agent and an adhesive, the skeleton agent includes mannitol, and the adhesive includes xanthan gum and pullulan.
[0021] The present invention uses the above-mentioned composition as the effective component, specifically selects mannitol as the skeleton agent, xanthan gum and pullulan as the adhesive, and the three cooperate with each other to synergistically enhance the effect, giving the whitening flash-release preparation a flash-release effect (disintegrates in the mouth within 3 to 5 seconds) and good stability (the prepared tablets do not have the problems of cracking, collapse and sticking to the bottom).
[0022] Preferably, the composition of the whitening flash-release preparation includes, by weight, 100 to 700 parts of a composition for inhibiting tyrosinase activity, 100 to 300 parts of mannitol, 20 to 100 parts of xanthan gum and 20 to 100 parts of pullulan.
[0023] Specific numerical values in the above 100 to 700 parts include, for example, 100 parts, 120 parts, 150 parts, 180 parts, 200 parts, 220 parts, 250 parts, 280 parts, 300 parts, 320 parts, 350 parts, 380 parts, 400 parts, 420 parts, 450 parts, 480 parts, 500 parts, 520 parts, 550 parts, 580 parts, 600 parts, 620 parts, 650 parts, 680 parts, 700 parts, etc.
[0024] Specific numerical values in the above 100 to 300 parts include, for example, 100 parts, 120 parts, 140 parts, 160 parts, 180 parts, 200 parts, 220 parts, 240 parts, 260 parts, 280 parts, 300 parts, and the like.
[0025] Specific numerical values in the above-mentioned 20 to 100 parts include 20 parts, 30 parts, 40 parts, 50 parts, 60 parts, 70 parts, 80 parts, 90 parts, 100 parts, etc., for example.
[0026] Compared with other ratios, the above-mentioned mass ratio can achieve the best synergistic effect between the components, which can achieve the best flash-release effect and stability of the whitening flash-release preparation.
[0027] Preferably, the whitening flash-release preparation also includes a sweetener (such as sucralose) and / or an edible flavor.
[0028] Preferably, the composition of the whitening flash-release preparation further includes 1 to 5 parts of sweeteners and / or 10 to 20 parts of edible flavors by weight.
[0029] Specific numerical values in the above 1 to 5 parts include 1 part, 2 parts, 3 parts, 4 parts, 5 parts, etc.
[0030] Specific numerical values in the above 10 to 20 parts include 10 parts, 12 parts, 14 parts, 16 parts, 18 parts, 20 parts, etc.
[0031] Preferably, the dosage form of the whitening flash-release preparation includes any one of tablets, granules, capsules, powders or pills, preferably tablets.
[0032] In a fifth aspect, the present invention provides a method for preparing the whitening flash-release preparation as described in the fourth aspect, the preparation method comprising: mixing and dissolving a composition for inhibiting tyrosinase activity, a skeleton agent, and an adhesive with water, and freeze-drying the mixture.
[0033] Preferably, the mixed dissolution further comprises mixed dissolution with a sweetener and / or an edible flavor.
[0034] Preferably, the mixed dissolution is carried out at 50-70°C, for example, 50°C, 55°C, 60°C, 65°C, 70°C, etc.
[0035] Preferably, the mixed dissolution is carried out under stirring.
[0036] Preferably, the stirring speed is 100-300 rpm, for example, 100 rpm, 120 rpm, 140 rpm, 160 rpm, 180 rpm, 200 rpm, 220 rpm, 240 rpm, 260 rpm, 280 rpm, 300 rpm, etc.
[0037] Preferably, the weight of the water is 2 to 3 times the total weight of other raw materials.
[0038] Preferably, the freeze-drying comprises: pre-freezing at -100 to -80°C for 5 to 10 minutes, and then freeze-drying at -80 to -70°C and a vacuum degree of 0.09 to 0.14 mbar for 5 to 10 hours.
[0039] Specific numerical values in the above-mentioned -100 to -80°C include, for example, -100°C, -95°C, -90°C, -85°C, and -80°C.
[0040] Specific numerical values of the above 5 to 10 min include 5 min, 6 min, 7 min, 8 min, 9 min, 10 min, etc.
[0041] Specific numerical values of the above-mentioned -80 to -70°C include -80°C, -78°C, -75°C, -72°C, -70°C and the like.
[0042] Specific numerical values in the above 0.09-0.14 mbar include 0.09 mbar, 0.1 mbar, 0.11 mbar, 0.12 mbar, 0.13 mbar, 0.14 mbar, etc.
[0043] Specific numerical values of the above 5 to 10 hours include 5h, 5.5h, 6h, 6.5h, 7h, 7.5h, 8h, 8.5h, 9h, 9.5h, 10h, etc.
[0044] Preferably, the freeze-drying step further includes degassing the mixed and dissolved solution.
[0045] Preferably, the degassing method includes vacuum degassing.
[0046] Preferably, the degassing time is 3 to 15 min, for example, 3 min, 4 min, 5 min, 6 min, 7 min, 8 min, 9 min, 10 min, 11 min, 12 min, 13 min, 14 min, 15 min, etc.
[0047] The present invention successfully achieves significantly shortening the preparation time while ensuring that the whitening flash-release preparation has excellent stability (without problems of fragmentation, collapse and sticking to the bottom) by coordinating various operations and parameters in the entire preparation method including mixed dissolution, degassing and freeze-drying.
[0048] The numerical range described in the present invention not only includes the point values listed above, but also includes any point values between the above numerical ranges that are not listed. Due to space limitations and for the sake of simplicity, the present invention no longer exhaustively lists the specific point values included in the range.
[0049] Compared with the prior art, the present invention has the following beneficial effects:
[0050] (1) The present invention creatively combines roxburghii powder, apple powder, cantaloupe powder and passion fruit powder. The four components cooperate with each other to have a synergistic effect in inhibiting tyrosinase activity, inhibiting melanin production and whitening effect, thereby achieving whitening from the source.
[0051] (2) Based on the above-mentioned functional composition, the present invention uses mannitol as a skeleton agent, pullulan and xanthan gum as adhesives, and makes a reasonable combination. The obtained whitening flash-release preparation (tablet) is safe and convenient to eat, melts in the mouth, can disintegrate in the mouth within 3 to 5 seconds, and releases the active ingredients, thus overcoming the problems of slow dissolution rate or difficulty in swallowing existing in traditional tablets (compressed candies and other products), avoiding the phenomenon of clumping and sticking to teeth due to slow dissolution rate, and also avoiding the risk of suffocation due to difficulty in swallowing; at the same time, because it can dissolve quickly in the mouth, the bioavailability of the functional ingredients is improved; and the whitening flash-release preparation has good stability, without the problems of fragmentation, collapse and sticking to the bottom.
[0052] (3) The present invention overcomes the problem of single variety of traditional oral beauty food preparations. The whitening flash-release preparation provided is rich in plant-derived SOD, VC and polyphenols, and can significantly inhibit tyrosinase activity and inhibit melanin from the source, thereby achieving the whitening effect.
[0053] (4) The present invention successfully achieves a significant reduction in preparation time while ensuring that the whitening flash-release preparation has excellent stability (no problems of fragmentation, collapse and sticking to the bottom) by coordinating various operations and parameters in the entire preparation method including mixed dissolution, degassing and freeze-drying. The preparation process is simple and suitable for industrial production.
[0054] (5) The raw and auxiliary materials used in the present invention are all food raw materials or additives, and are widely available and low in cost. BRIEF DESCRIPTION OF THE DRAWINGS
[0055] Figure 1 It is the tyrosinase inhibition rate result of whitening flash-release tablets and positive control (arbutin). DETAILED DESCRIPTION
[0056] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only used to help understand the present invention and should not be regarded as specific limitations of the present invention.
[0057] In the following examples, unless otherwise specified, all reagents and consumables were purchased from conventional reagent manufacturers in the field; unless otherwise specified, the experimental methods and technical means used were conventional methods and means in the field.
[0058] Cantaloupe powder was purchased from Shanghai Chengyi Health Technology Group Co., Ltd., item number: 0012000134;
[0059] Rosa roxburghii powder was purchased from Guangdong Qingyunshan Pharmaceutical Co., Ltd., item number: 20210301;
[0060] Passion fruit powder was purchased from: MORINAGA Company, item number: 211011;
[0061] Apple powder was purchased from BGG Company, item number: 220523APE-020.
[0062] Example 1
[0063] This embodiment provides a whitening instant release tablet, and the preparation process is as follows:
[0064] (1) Weigh 20 parts of cantaloupe powder, 150 parts of roxburghii powder, 30 parts of passion fruit powder, 150 parts of apple powder, 193 parts of mannitol, 20 parts of pullulan, 20 parts of xanthan gum, 2 parts of sucralose, and 15 parts of edible flavor, place them in a batching tank, add 2.5 times (2.5 times the total mass of the raw materials in the batching) of purified water to dissolve, control the temperature to 60° C., and stir at a speed of 150 rpm;
[0065] (2) After the raw materials are fully dissolved, vacuum degassing is performed for 8 minutes; the liquid is dispensed into the blister eyes of the aluminum-plastic blister plate at 0.5 mL / piece, and the blister plate filled with the liquid is placed in a -90°C refrigerator for pre-freezing for 8 minutes;
[0066] (3) The pre-frozen blister plate is transferred to the freeze dryer plate layer, the temperature is set to -75°C, the vacuum degree is 0.11 mbar, and the drying is performed for 8 hours to obtain the whitening flash-release tablets.
[0067] Example 2
[0068] This embodiment provides a whitening instant release tablet, and the preparation process is as follows:
[0069] (1) Weigh 30 parts of cantaloupe powder, 200 parts of roxburghii powder, 20 parts of passion fruit powder, 100 parts of apple powder, 167 parts of mannitol, 30 parts of pullulan, 30 parts of xanthan gum, 3 parts of sucralose, and 20 parts of edible flavor, place them in a mixing tank, add 3 times the mass of purified water to dissolve, control the temperature to 65° C., and stir at a speed of 200 rpm;
[0070] (2) After the raw materials are fully dissolved, vacuum degassing is performed for 10 minutes; the liquid is dispensed into the blister holes of the aluminum-plastic blister plate at 0.5 mL / piece, and the blister plate filled with the liquid is placed in a -100°C refrigerator for pre-freezing for 5 minutes;
[0071] (3) The pre-frozen blister plate was transferred to the freeze dryer plate layer, the temperature was set to -70°C, the vacuum degree was 0.12 mbar, and the blister plate was dried for 10 hours to obtain the whitening flash-release tablets.
[0072] Example 3
[0073] This embodiment provides a whitening instant release tablet, and the preparation process is as follows:
[0074] (1) Weigh 10 parts of cantaloupe powder, 250 parts of roxburghii powder, 40 parts of passion fruit powder, 50 parts of apple powder, 189 parts of mannitol, 25 parts of pullulan, 25 parts of xanthan gum, 1 part of sucralose, and 10 parts of edible flavor, place them in a mixing tank, add 2 times the mass of purified water to dissolve, control the temperature to 55° C., and stir at a speed of 100 rpm;
[0075] (2) After the raw materials are fully dissolved, vacuum degassing is performed for 5 minutes; the liquid is dispensed into the blister eyes of the aluminum-plastic blister plate at 0.5 mL / piece, and the blister plate filled with the liquid is placed in a -80°C refrigerator for pre-freezing for 10 minutes;
[0076] (3) The pre-frozen blister plate is transferred to the freeze dryer plate layer, the temperature is set to -80°C, the vacuum degree is 0.10 mbar, and the blister plate is dried for 5 hours to obtain the whitening flash-release tablets.
[0077] Comparative Example 1
[0078] This comparative example provides a whitening flash-release tablet, and the preparation process thereof is different from that of Example 3 only in that passion fruit powder is lacking in the raw material, and the lacking amount is distributed to cantaloupe powder, sea buckthorn powder and apple powder in proportion, and other conditions refer to Example 1.
[0079] Comparative Example 2
[0080] This comparative example provides a whitening flash-release tablet, and the preparation process thereof is different from that of Example 3 only in that: apple powder is lacking in the raw materials, and the lacking amount is distributed to cantaloupe powder, sea buckthorn powder and passion fruit powder in proportion, and other conditions refer to Example 1.
[0081] Comparative Example 3
[0082] This comparative example provides a whitening flash-release tablet, and the preparation process thereof is different from that of Example 3 only in that: cantaloupe powder is lacking in the raw materials, and the lacking amount is distributed to apple powder, roxburghii powder and passion fruit powder in proportion, and other conditions refer to Example 1.
[0083] Comparative Example 4
[0084] This comparative example provides a whitening flash-release tablet, and the preparation process thereof is different from that of Example 3 only in that: the raw material lacks roxburghii powder, and the lacking amount is distributed to apple powder, cantaloupe powder and passion fruit powder in proportion, and other conditions refer to Example 1.
[0085] Test Example 1-Tyrosinase Activity Inhibition Experiment
[0086] Tyrosinase is the key rate-limiting enzyme for tyrosine to generate melanin through a series of biochemical reactions. Tyrosine is converted into dopachrome under the catalysis of tyrosinase, which has characteristic absorption at 475nm, so the activity of tyrosinase can be measured by colorimetry.
[0087] A 0.5 mg / mL L-tyrosine solution and a 100 μg / mL tyrosinase solution were prepared using a phosphate buffer solution with a pH of 6.8 as a solvent. A 1 mg / mL arbutin solution (positive control sample) and whitening flash-release tablets (test samples) prepared in various embodiments and comparative examples at different concentrations (3.43-13.71 mg / mL) were prepared using water as a solvent. The tyrosine solution, tyrosinase solution and sample solution were mixed evenly, placed at room temperature for reaction for 30 minutes, and the absorbance was measured at 475 nm as a sample group (including a positive control sample and a test sample); a sample blank group was set up: except for not adding tyrosinase solution, other operations were referred to the sample group; a control group: the sample solution was replaced with water, and other operations were referred to the sample group; a control blank group: except for not adding tyrosinase solution, other operations were referred to the control group.
[0088] The inhibition rate of tyrosinase activity of the whitening flash-release tablets sample was calculated according to the following formula:
[0089]
[0090] Arbutin was used as a positive control in this experiment. A scatter plot with smooth lines and data markers was made with the concentration of the sample to be tested as the X-axis and the absorbance as the Y-axis. The upper, middle and lower three points with an inhibition rate of about 50% were selected as a straight line to obtain the straight line equation, and the tyrosinase inhibition IC of the whitening flash-release tablets and arbutin was preliminarily estimated. 50 value.
[0091] The results of the tyrosinase inhibition activity test of each group of whitening flash-release tablets are shown in Figure 1 .
[0092] The results show that at a concentration of 13.71 mg / mL, the whitening flash-release tablets of Examples 1 to 3 have tyrosinase activity inhibition rates of 73.82%, 89.13%, and 96.97%, respectively, and the corresponding IC50 values are 11.00 mg / mL, 8.59 mg / mL, and 5.21 mg / mL, respectively. Example 1 (73.82%) can achieve the inhibitory effect of the positive control arbutin (inhibition rate 74.76%) on tyrosinase activity, and the effects of Examples 2 and 3 have been further significantly improved. The inhibition rates of comparative examples 1 to 4 on tyrosinase activity are 39.87%, 60.57%, 52.39%, and 20.41%, respectively. This experimental result shows that the flash-release tablets of the present invention have certain whitening effects, but the whitening effect of the flash-release tablets lacking any raw material is much lower than that of the flash-release tablets obtained by combining the raw materials, indicating that the four raw materials of roxburghii powder, apple powder, melon powder, and passion fruit powder have a synergistic effect in inhibiting tyrosinase activity and whitening effect.
[0093] Test Example 2-Flash Release Effect Test
[0094] Test the disintegration time of whitening flash-release tablets:
[0095] Experimental method: Fix the disintegration basket on the bracket and immerse it in a 500mL cup containing about 450mL of water at a temperature of 37±1℃, with the bottom of the basket 15±1mm below the water surface. Place one piece of sample in the disintegration basket and record the time it takes for the sample to completely disintegrate and pass through the 710μm sieve.
[0096] The experimental results are shown in Table 1.
[0097] Table 1
[0098] sample Disintegration time (seconds) Example 1 4 Example 2 4 Example 3 3 Comparative Example 1 5 Comparative Example 2 5 Comparative Example 3 3 Comparative Example 4 5
[0099] Conclusion: The disintegration time of the flash-release tablets prepared by the present invention is within 5 seconds, and the flash-release effect is successfully achieved.
[0100] The disintegration speed of Examples 1 and 2 is slower than that of Example 3 because the freeze-drying time is longer than that of Example 3. The disintegration speed of the flash-release tablet prepared in Comparative Example 3 is faster than that of other Comparative Examples because of the lack of cantaloupe powder with poor solubility.
[0101] The applicant declares that the present invention illustrates a composition for inhibiting tyrosinase activity and its application through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.
[0102] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.
[0103] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.
Claims
1. A whitening flash-release preparation, It is characterized in that The whitening flash-release preparation is composed of 100 to 700 parts of a composition for inhibiting tyrosinase activity, 100 to 300 parts of mannitol, 20 to 100 parts of xanthan gum and 20 to 100 parts of pullulan in parts by weight; The composition is composed of 5 to 50 parts of cantaloupe powder, 50 to 300 parts of roxburghii powder, 15 to 60 parts of passion fruit powder and 40 to 200 parts of apple powder in parts by weight; The whitening flash-release preparation is prepared by a method comprising the following steps: mixing and dissolving a composition for inhibiting tyrosinase activity, mannitol, xanthan gum, and pullulan with water, and freeze-drying the mixture to obtain the preparation.
2. The whitening flash-release preparation according to claim 1, It is characterized in that The composition consists of 5 to 50 parts of cantaloupe powder, 200 to 300 parts of roxburghii powder, 15 to 60 parts of passion fruit powder and 40 to 200 parts of apple powder in parts by weight.
3. The whitening flash-release preparation according to claim 1, It is characterized in that The composition consists of 5 to 15 parts of cantaloupe powder, 220 to 280 parts of roxburghii powder, 30 to 50 parts of passion fruit powder and 40 to 60 parts of apple powder in parts by weight.
4. The whitening flash-release preparation according to claim 1, It is characterized in that The dosage form of the whitening flash-release preparation includes any one of tablets, granules, capsules, powders or pills.
5. A method for preparing the whitening flash-release preparation according to any one of claims 1 to 4, It is characterized in that The preparation method comprises: mixing and dissolving the composition for inhibiting tyrosinase activity, mannitol, xanthan gum, pullulan and water, and freeze-drying the mixture to obtain the product.
6. The method for preparing the whitening flash-release preparation according to claim 5, It is characterized in that The mixed dissolution is carried out at 50-70°C.
7. The preparation method of the whitening flash-release preparation according to claim 5, It is characterized in that The mixed dissolution is carried out under stirring.
8. The method for preparing the whitening flash-release preparation according to claim 7, It is characterized in that The stirring speed is 100-300 rpm.
9. The method for preparing the whitening flash-release preparation according to claim 5, It is characterized in that The weight of the water is 2 to 3 times the total weight of other raw materials.
10. The method for preparing the whitening flash-release preparation according to claim 5, It is characterized in that The freeze drying comprises: pre-freezing at -100 to -80°C for 5 to 10 minutes, and then freeze drying at -80 to -70°C and a vacuum degree of 0.09 to 0.14 mbar for 5 to 10 hours.
11. The method for preparing the whitening flash-release preparation according to claim 5, It is characterized in that The freeze-drying step also includes degassing the mixed and dissolved solution.
12. The method for preparing the whitening flash-release preparation according to claim 11, It is characterized in that The degassing method includes vacuum degassing.
13. The method for preparing the whitening flash-release preparation according to claim 11, It is characterized in that The degassing time is 3 to 15 minutes.
Citation Information
Patent Citations
Wintercherry active extract as well as extraction method and application thereof
CN108033970A
Freeze-dried flash-release tablet and preparation method thereof
CN112870173A
γ-aminobutyric acid (GABA) lyophilized flash-release tablets and their preparation method
CN112971150B
Probiotic fruit and vegetable enzyme drink and preparation method thereof
CN107348272A
